Aqua Bio Technology ASA (Oslo Axess: ABT) recently announced its first quarter 2013 financial results. The Company continued its revenue build-up and posted an EBITDA of 3.9 million.
ABT’s revenues were NOK 7.2 million in the first quarter, against NOK 3.4 million in the previous quarter. In the first quarter of 2012 the Company had revenues of NOK 11.9 million, which included sign-on fees for major contracts.
The sales growth is reflected in the NOK 3.9 million EBITDA, which is up from an EBITDA of NOK 0.2 million the previous quarter. The first quarter of 2012 provided EBITDA of NOK 9.6 million.
Aqua Bio Technology ASA (ABT) develops, produces and markets patented ingredients and technologies to the international cosmetic and skin care industry. ABT’s ingredients Aquabeautine XL, Dermaclarine and Beauty Propelline are marine solutions derived from the hatching fluid of salmon, while Oceanx Oil in Serum is based on extract from seaweed.
Scientists working for the SPLASH research project, funded by the EU, are now addressing the challenge of making high-quality, affordable plastics from algae. They need to demonstrate that this new type of bioplastic —namely used to produce polyesters and polyolefins— can be of the same quality as traditional plastic. And they need to show whether it can be produced in an economically viable way.
Although terrestrial myxobacteria have been extensively studied and are known to produce a range of secondary metabolites with a remarkable variety of unusual structures, their marine counterparts have only recently been discovered.
Gabriele M. König and co-workers, University of Bonn, Germany, have isolated a marine myxobacterium from a mud sample from the coast of the island Prerow, Germany. Analysis showed that the bacterium was Enhygromyxa salina, which is closely related to microorganisms previously termed “unculturable”. As this bacterium was found to have persistent antibiotic activity towards gram-positive microorganisms, it was chosen for detailed investigation.
It was only a matter of time before scientists found a way to recycle the 750 000 tonnes of crustacean shells which are disposed of in the EU every year.
Asia has successfully managed to extract polymer chitosan (used to make filters, foils and wound dressings) produced from shrimp shells. But in Europe crustaceans contain more lime, so processing is more complex and not economical. Also, the high content of calcium carbonate (known as CaCO3) of EU crab shell waste has prevented cost effective conversions to chitosan so far.
However, a solution has come from the ChiBio Project, which is developing an integrated biorefinery for processing chitin rich biowaste, to specialty and fine chemicals. ChiBio is led by the Straubing Project Group BioCat of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, with a consortium of 11 European partners and has been awarded EU funding of nearly EUR 3 million.
Algaeon Inc., an Indianapolis-based biotech company that has developed algae cultivation technology for use in the nutraceutical and micronutrient markets, announced today that it has closed a $770,000 investment round of funding from early-stage growth company investors. The investment group included City Securities Corporation and multiple individual Angel investors.
The funding will support the addition of capacity for sample qualification and animal testing for 3 prospective customers and the design of a commercial scale facility. This sets the ground work for the Company to expand operations and to produce products used as food supplements to promote health and disease prevention for humans and animals.
Scientists at Nofima are participating in a major EU-financed project in which “active” packaging based on raw materials from shrimp shell improves and conserves food products – and after use the packaging biodegrades. Environmentally stubborn plastic is getting competition from biodegradable packaging made of chitin and chitosan from shrimp shell.
Nofima’s part of the project equates to around NOK 1 million over a two-year period. Together with the coordinator, Italian company Mavi, the majority of the project involves four medium-sized companies in EU and three research centres.
“Our job is to ensure food contact safety in the project and quantify the effect on bacteria. Chitosan used as an integrated part of the packaging can have an antibacterial effect on the food products,” says Morten Sivertsvik, Director of Research at Nofima’s department for Processing Technology in Stavanger.
“The EU has strict regulations in this area, and our role is to see that the active packaging have a positive and not negative impact on the food products. The chitosan-based fibres that are used in the packaging are based on nanotechnology, so we are talking about minute particles that by no means have to break down so they come in the food products.”
Sivertsvik has worked on packaging technology at Nofima, Europe’s largest food research institute, since 1992.
Supreme Biotechnologies, producers of AstaSupreme Astaxanthin, have launched a unique formula which combines Astaxanthin, Curcumin and Omega 3.
Supreme Biotechnologies CEO Tony Dowd says the new product is designed specifically to target inflammation in sore joints and tendons, by combining three ingredients that have been clinically validated as natural anti-inflammatory agents.
“Many people suffering from painful inflamed joints often take Astaxanthin, Curcumin and Omega 3 separately,” Dowd says. “So, we worked with a natural health consultant to combine the right quantities of each of these three ingredients, to create a powerhouse formula for painful joints.
Primex has introducted a microencapsulated version of its LipoSan Ultra that is designed for weight loss beverages.
The new and unique weight loss ingredient is an innovative development and line extension of Primex’s ordinary weight loss ingredient LipoSan Ultra, a patented product based on ChitoClear chitosan and succinic acid, which has an extraordinary ability to bind to dietary fat so it is not absorbed by the body.
The original product has been used as a food supplement for weight management. LipoSan Ultra chitosan is a dietary fiber and will as such improve the nutritional value of the functional food consumed, the company said.
Developing a new generation of energy-producing construction components, Grow Energy, of San Diego, California, plans for algae to create clean electricity for residential and commercial structures. Their first system, called Verde, is a technology specifically designed for individual homes. According to the company, Verde employs a clean combustion process to burn algal biomass to create electricity and heat energy, which can significantly offset a property’s utility expenses, if not supplement the entirety of a property’s electricity needs.
The Verde system photobioreactors are algae panels that mount onto a building’s roof or envelope and grow algae by using recycled elements and nutrients in a closed-loop process. Designed to be minimally invasive, the system is compact and meant to be no more intrusive to a home’s aesthetics than solar technology. Grow Energy plans to introduce Verde to the mainstream homeowner market in 2015.
MDPI has announced the publication of the following issue:
Mar. Drugs, Volume 11, Issue 3 (March 2013), Pages Pages 581-974
Table of Contents:
Editorial: Marine Drugs Best Paper Award 2013
Mar. Drugs 2013, 11(3), 581-583; doi:10.3390/md11030581
Marco Pelin, Sabrina Boscolo, Mark Poli, Silvio Sosa, Aurelia Tubaro and Chiara Florio
Article: Characterization of Palytoxin Binding to HaCaT Cells Using a Monoclonal Anti-Palytoxin Antibody
Mar. Drugs 2013, 11(3), 584-598; doi:10.3390/md11030584
Jean-Baptiste Gallé, Barthélémy Attioua, Marcel Kaiser, Anne-Marie Rusig, Annelise Lobstein and Catherine Vonthron-Sénécheau
Article: Eleganolone, a Diterpene from the French Marine Alga Bifurcaria bifurcata Inhibits Growth of the Human Pathogens Trypanosoma brucei and Plasmodium falciparum
Mar. Drugs 2013, 11(3), 599-610; doi:10.3390/md11030599
Soohyun Um, Yuna Pyee, Eun-Hee Kim, Sang Lee, Jongheon Shin and Dong-Chan Oh
Article: Thalassospiramide G, a New γ-Amino-Acid-Bearing Peptide from the Marine BacteriumThalassospira sp.
Mar. Drugs 2013, 11(3), 611-622; doi:10.3390/md11030611
Gerrit Gerwig, Henry Hocking, Reto Stöcklin, Johannis Kamerling and Rolf Boelens
Review: Glycosylation of Conotoxins
Mar. Drugs 2013, 11(3), 623-642; doi:10.3390/md11030623
Anna Carbone, Barbara Parrino, Paola Barraja, Virginia Spanò, Girolamo Cirrincione, Patrizia Diana, Armin Maier, Gerhard Kelter and Heinz-Herbert Fiebig
Article: Synthesis and Antiproliferative Activity of 2,5-bis(3′-Indolyl)pyrroles, Analogues of the Marine Alkaloid Nortopsentin
Mar. Drugs 2013, 11(3), 643-654; doi:10.3390/md11030643
Diego Orts, Steve Peigneur, Bruno Madio, Juliana Cassoli, Gabriela Montandon, Adriano Pimenta, José Bicudo, José Freitas, André Zaharenko and Jan Tytgat
Article: Biochemical and Electrophysiological Characterization of Two Sea Anemone Type 1 Potassium Toxins from a Geographically Distant Population of Bunodosoma caissarum
Mar. Drugs 2013, 11(3), 655-679; doi:10.3390/md11030655
Heidi Hannon and William Atchison
Review: Omega-Conotoxins as Experimental Tools and Therapeutics in Pain Management
Mar. Drugs 2013, 11(3), 680-699; doi:10.3390/md11030680
Zhi-Qiang Xiong, Jian-Feng Wang, Yu-You Hao and Yong Wang
Review: Recent Advances in the Discovery and Development of Marine Microbial Natural Products
Mar. Drugs 2013, 11(3), 700-717; doi:10.3390/md11030700
Xiaohong Wang, Heinz Schröder, Qingling Feng, Florian Draenert and Werner Müller
Review: The Deep-Sea Natural Products, Biogenic Polyphosphate (Bio-PolyP) and Biogenic Silica (Bio-Silica), as Biomimetic Scaffolds for Bone Tissue Engineering: Fabrication of a Morphogenetically-Active Polymer
Mar. Drugs 2013, 11(3), 718-746; doi:10.3390/md11030718
José Vázquez, Isabel Rodríguez-Amado, María Montemayor, Javier Fraguas, María González and Miguel Murado
Review: Chondroitin Sulfate, Hyaluronic Acid and Chitin/Chitosan Production Using Marine Waste Sources: Characteristics, Applications and Eco-Friendly Processes: A Review
Mar. Drugs 2013, 11(3), 747-774; doi:10.3390/md11030747
Zenglei Wang, Hua Tang, Pan Wang, Wei Gong, Mei Xue, Hongwei Zhang, Taofang Liu, Baoshu Liu, Yanghua Yi and Wen Zhang
Article: Bioactive Polyoxygenated Steroids from the South China Sea Soft Coral, Sarcophyton sp.
Mar. Drugs 2013, 11(3), 775-787; doi:10.3390/md11030775
Chi-Jen Tai, Jui-Hsin Su, Chiung-Yao Huang, Ming-Shyan Huang, Zhi-Hong Wen, Chang-Feng Dai and Jyh-Horng Sheu
Article: Cytotoxic and Anti-Inflammatory Eunicellin-Based Diterpenoids from the Soft Coral Cladiella krempfi
Mar. Drugs 2013, 11(3), 788-799; doi:10.3390/md11030788
Nils Jansen, Birgit Ohlendorf, Arlette Erhard, Torsten Bruhn, Gerhard Bringmann and Johannes Imhoff
Article: Helicusin E, Isochromophilone X and Isochromophilone XI: New Chloroazaphilones Produced by the Fungus Bartalinia robillardoides Strain LF550
Mar. Drugs 2013, 11(3), 800-816; doi:10.3390/md11030800
Ganjun Yuan, Kui Hong, Haipeng Lin, Zhigang She and Jia Li
Article: New Azalomycin F Analogs from Mangrove Streptomyces sp. 211726 with Activity against Microbes and Cancer Cells
Mar. Drugs 2013, 11(3), 817-829; doi:10.3390/md11030817
Victoria Suárez-Ulloa, Juan Fernández-Tajes, Vanessa Aguiar-Pulido, Ciro Rivera-Casas, Rodrigo González-Romero, Juan Ausio, Josefina Méndez, Julián Dorado and José Eirín-López
Article: The CHROMEVALOA Database: A Resource for the Evaluation of Okadaic Acid Contamination in the Marine Environment Based on the Chromatin-Associated Transcriptome of the Mussel Mytilus galloprovincialis
Mar. Drugs 2013, 11(3), 830-841; doi:10.3390/md11030830
Xiuli Xu, Liyuan Yin, Lijie Gao, Junhai Gao, Junhui Chen, Jingxi Li and Fuhang Song
Article: Two New Bromophenols with Radical Scavenging Activity from Marine Red AlgaSymphyocladia latiuscula
Mar. Drugs 2013, 11(3), 842-847; doi:10.3390/md11030842
M. Rashid, Somayeh Mahdavi and Serdar Kuyucak
Review: Computational Studies of Marine Toxins Targeting Ion Channels
Mar. Drugs 2013, 11(3), 848-869; doi:10.3390/md11030848
Chao-Yan Zhang, Ting Kong, Wen-Hui Wu and Min-Bo Lan
Article: The Protection of Polysaccharide from the Brown Seaweed Sargassum graminifoliumagainst Ethylene Glycol-Induced Mitochondrial Damage
Mar. Drugs 2013, 11(3), 870-880; doi:10.3390/md11030870
María Hortigüela and J. Wall
Article: Improved Detection of Domoic Acid Using Covalently Immobilised Antibody Fragments
Mar. Drugs 2013, 11(3), 881-895; doi:10.3390/md11030881
Yutaka Hata, Shikshya Timalsina and Sainawaer Maimaiti
Review: Okadaic Acid: A Tool to Study the Hippo Pathway
Mar. Drugs 2013, 11(3), 896-902; doi:10.3390/md11030896
Ying-Qing Wang and Ze-Hong Miao
Review: Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
Mar. Drugs 2013, 11(3), 903-933; doi:10.3390/md11030903
Camila Lehnhardt Pires, Selma Rodrigues, Daniel Bristot, Henrique Gaeta, Daniela de Oliveira Toyama, Wladimir Lobo Farias and Marcos Toyama
Article: Evaluation of Macroalgae Sulfated Polysaccharides on the Leishmania (L.) amazonensisPromastigote
Mar. Drugs 2013, 11(3), 934-943; doi:10.3390/md11030934
Maria Serova, Armand de Gramont, Ivan Bieche, Maria Riveiro, Carlos Galmarini, Miguel Aracil, José Jimeno, Sandrine Faivre and Eric Raymond
Article: Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine Compound
Mar. Drugs 2013, 11(3), 944-959; doi:10.3390/md11030944
Ling-Yan Dong, Jie Jin, Gao Lu and Xiao-Li Kang
Article: Astaxanthin Attenuates the Apoptosis of Retinal Ganglion Cells in db/db Mice by Inhibition of Oxidative Stress
Mar. Drugs 2013, 11(3), 960-974; doi:10.3390/md11030960